Search Results - "Gaylis, Franklin D."

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Gaylis, Franklin D, Emond, Bruno, Manceur, Ameur M, Tardif-Samson, Anabelle, Morrison, Laura, Pilon, Dominic, Lefebvre, Patrick, Ellis, Lorie A, Balaji, Hiremagalur, Ireland, Andrea

“…Bacillus Calmette-Guérin (BCG) can reduce recurrence and delay progression among patients with high-risk non-muscle invasive bladder cancer (NMIBC), but is…”
Get full text

Genetic factors associated with prostate cancer conversion from active surveillance to treatment by Jiang, Yu, Meyers, Travis J., Emeka, Adaeze A., Cooley, Lauren Folgosa, Cooper, Phillip R., Lancki, Nicola, Helenowski, Irene, Kachuri, Linda, Lin, Daniel W., Stanford, Janet L., Newcomb, Lisa F., Kolb, Suzanne, Finelli, Antonio, Fleshner, Neil E., Komisarenko, Maria, Eastham, James A., Ehdaie, Behfar, Benfante, Nicole, Logothetis, Christopher J., Gregg, Justin R., Perez, Cherie A., Garza, Sergio, Kim, Jeri, Marks, Leonard S., Delfin, Merdie, Barsa, Danielle, Vesprini, Danny, Klotz, Laurence H., Loblaw, Andrew, Mamedov, Alexandre, Goldenberg, S. Larry, Higano, Celestia S., Spillane, Maria, Wu, Eugenia, Carter, H. Ballentine, Pavlovich, Christian P., Mamawala, Mufaddal, Landis, Tricia, Carroll, Peter R., Chan, June M., Cooperberg, Matthew R., Cowan, Janet E., Morgan, Todd M., Siddiqui, Javed, Martin, Rabia, Klein, Eric A., Brittain, Karen, Gotwald, Paige, Barocas, Daniel A., Dallmer, Jeremiah R., Gordetsky, Jennifer B., Steele, Pam, Kundu, Shilajit D., Stockdale, Jazmine, Roobol, Monique J., Venderbos, Lionne D.F., Sanda, Martin G., Arnold, Rebecca, Patil, Dattatraya, Evans, Christopher P., Dall’Era, Marc A., Vij, Anjali, Costello, Anthony J., Chow, Ken, Corcoran, Niall M., Rais-Bahrami, Soroush, Phares, Courtney, Scherr, Douglas S., Flynn, Thomas, Karnes, R. Jeffrey, Koch, Michael, Dhondt, Courtney Rose, Nelson, Joel B., McBride, Dawn, Cookson, Michael S., Stratton, Kelly L., Farriester, Stephen, Hemken, Erin, Stadler, Walter M., Pera, Tuula, Banionyte, Deimante, Bianco, Fernando J., Lopez, Isabel H., Loeb, Stacy, Taneja, Samir S., Byrne, Nataliya, Amling, Christopher L., Martinez, Ann, Boileau, Luc, Gaylis, Franklin D., Petkewicz, Jacqueline, Kirwen, Nicholas, Helfand, Brian T., Xu, Jianfeng, Scholtens, Denise M., Catalona, William J., Witte, John S.

“…Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce…”
Get full text

Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US by Cooperberg, Matthew R, Meeks, William, Fang, Raymond, Gaylis, Franklin D, Catalona, William J, Makarov, Danil V

“…Active surveillance (AS) is endorsed by clinical guidelines as the preferred management strategy for low-risk prostate cancer, but its use in contemporary…”
Get full text

Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation by Leapman, Michael S, Wang, Rong, Loeb, Stacy, Seibert, Tyler M, Gaylis, Franklin D, Lowentritt, Ben, Brown, Gordon A, Chen, Ronald, Lin, Daniel, Witte, John, Cooperberg, Matthew R, Catalona, William J, Gross, Cary P, Ma, Xiaomei

“…It is unknown whether compliance with recommended monitoring tests during observation of localized prostate cancer has changed over time. We performed a…”
Get full text

Trends in Metastatic Breast and Prostate Cancer by Gaylis, Franklin D, Choi, Jae, Kader, A Karim

Get full text

Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice by Gaylis, Franklin D., Choi, Jae E., Hamilton, Zachary, Dato, Paul, Cohen, Edward, Calabrese, Renee, Prime, Hilary, Rosenbaum, Aaron, Kader, Andrew Karim

“…The benefits of prostate-specific antigen (PSA)–based prostate cancer screening are controversial. We sought to determine the change in prostate cancer…”
Get full text

Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter by Gaylis, Franklin D., Cooperberg, Matthew R., Chen, Ronald C., Malin, Jennifer, Loeb, Stacy, Witte, John S., Carroll, Peter R., Cohen, Edward S., Dato, Paul E., Lin, Daniel W., Zheng, Yingye, Seibert, Tyler M., Setzler, Christopher, Wilt, Wanda, Gomez, Scarlett L., Chan, June M. L., Catalona, William J.

Get full text

A vision for closing the evidence-practice gap in the management of low-grade prostate cancer by Leapman, Michael S, Loeb, Stacy, Cooperberg, Matthew R, Catalona, William J, Gaylis, Franklin D

Get full text

Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients with Low-Risk Prostate Cancer in the Community Practice by Gaylis, Franklin D, Leapman, Michael S, Ellis, Shellie D, Hu, Steven, Cooperberg, Matthew R, Loeb, Stacy, Chen, Ronald C, Cohen, Edward S, Dato, Paul E, Aynehchi, Shahrad, David, Richard, Topp, Robert, Santomauro, Bianca, Ginsburg, Kevin, Catalona, William J

Get full text

Re: Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends. L. Budäus, F. Abdollah, M. Sun, M. Morgan, R. Johal, R. Thuret, K. C. Zorn, H. Isbarn, S. F. Shariat, F. Montorsi, P. Perrotte, M. Graefen and P. I. Karakiewicz. J Urol 2010; 184: 2285-2290 by Gaylis, Franklin D, Sass, Maggie

Get more information

Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care by Gaylis, Franklin D, Cooperberg, Matthew R, Loeb, Stacy, Chen, Ronald C, Seibert, Tyler M, Cohen, Edward, Dato, Paul, Emeka, Adaeze A, Prime, Rose, Romo, Sonia, Catalona, William J

Get full text

Prostate cancer in men using testosterone supplementation by Gaylis, Franklin D, Lin, Daniel W, Ignatoff, Jeffrey M, Amling, Christopher L, Tutrone, Ronald F, Cosgrove, Daniel J

“…Although an association between testosterone supplementation and the development of prostate cancer is unproven, a recent increase in the use of this therapy…”
Get more information

Preprinted Standardized Orders Promote Venous Thromboembolism Prophylaxis Compared With Traditional Handwritten Orders: An Endorsement of Standardized Evidence-Based Practice by Gaylis, Franklin D., Van, Sothary J., Daneshvar, Michael A., Gaylis, Gregory M., Gaylis, Jaclyn B., Sheela, Rose B., Stern, Electa J., Hanson, Peter B., Sur, Roger L.

“…The objective was to determine if a standardized process of care—namely, standardized evidence-based medical orders (SEBMOs)—improves physician compliance with…”
Get full text

Study of real-world treatment patterns and adherence to bacillus Calmette-Guerin (BCG) in the context of guideline recommendations for patients with high-risk non-muscle invasive bladder cancer (NMIBC) by Gaylis, Franklin D, Emond, Bruno, Manceur, Ameur M, Tardif-Samson, Anabelle, Morrison, Laura, Pilon, Dominic, Lefebvre, Patrick, Ellis, Lorie, Balaji, Hiremagalur parthasarathy, Ireland, Andrea

“…470 Background: Intravesical BCG is considered a first-line (1L) treatment for high-risk NMIBC patients. Since the presence of carcinoma in situ (CIS) in NMIBC…”
Get full text

PD13-06 IMPLEMENTATION OF PRACTICE-LEVEL INTERVENTIONS FOR LOW-RISK PROSTATE CANCER IN A COMMUNITY PRACTICE by Gaylis, Franklin D., Leapman, Michael, Ellis, Shellie D., Hu, Steven, Cooperberg, Matthew R., Loeb, Stacy, Chen, Ronald C., Cohen, Edward S., Dato, Paul E., Aynehchi, Shahrad, David, Richard, Topp, Robert, Catalona, William

Get full text

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Gaylis, Franklin, Emond, Bruno, Manceur, Ameur, Tardif-Samson, Anabelle, Morrison, Laura, Pilon, Dominic, Lefebvre, Patrick, Ellis, Lorie, Balaji, Hiremagalur, Ireland, Andrea

“…Background: Bacillus Calmette-Guérin (BCG) can reduce recurrence and delay progression among patients with high-risk non–muscle invasive bladder cancer…”
Get full text

Trends in Metastatic Breast and Prostate Cancer by Gaylis, Franklin D, Choi, Jae, Kader, A. Karim, Eby, Peter R, Fouad, Tamer M, Welch, H. Gilbert, Gorski, David H, Albertsen, Peter C

“…To the Editor: In reporting on the effect of prostate-cancer screening, Welch et al. (Oct. 29 issue) 1 suggest that since the introduction of prostate-specific…”
Get full text

Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter by Gaylis, Franklin D, Cooperberg, Matthew R, Chen, Ronald C, Malin, Jennifer, Loeb, Stacy, Witte, John S, Carroll, Peter R, Cohen, Edward S, Dato, Paul E, Lin, Daniel W, Zheng, Yingye, Seibert, Tyler M, Setzler, Christopher, Wilt, Wanda, Gomez, Scarlett L, Chan, June M L, Catalona, William J

Get full text

Radical retropubic prostatectomy outcomes at a community hospital by Gaylis, F D, Friedel, W E, Armas, O A

“…We reviewed a 6-year experience performing radical retropubic prostatectomy at 2 community hospitals (for-profit and not-for-profit) to assess outcomes and to…”
Get more information

Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype by Gaylis, F D, Keer, H N, Wilson, M J, Kwaan, H C, Sinha, A A, Kozlowski, J M

“…The levels of several tumor associated proteases, including plasminogen activators (PA), are elevated in many malignant tumors compared to their benign tumor…”
Get more information